 | Your browser does not display parts of our website correctly. We use the latest technology available to provide you with a high quality experience; please upgrade your browser to its latest version to view the contents properly: |
Catamaran Corporation (CTRX) provides pharmacy benefit management (PBM) services and healthcare information technology solutions to the healthcare benefits management industry in North America.
The company offers informedRx, a suite of PBM services; and RxCLAIM, an online transaction processing system to provide online adjudication of third-party prescription drug claims at the point of service, such as claims management and review, as well as payment and billing support and real-time functionality for updating benefit, price, member, provider, and drug details.
It also provides Integrail Pathfinder, a software application that enables the users to understand the impact of healthcare resource allocation and medical decision-making; IntegrailRx, which measures and predicts both pharmacy and total risk using pharmacy claims; RxBUILDER, a Web-based interface for formulary creation and maintenance; RxPORTAL, which allows customers to interact with the patients formulary and drug history; RxAUTH, a prior authorization (PA) management solution for automating PA process; and RxTRACK, a data warehouse and analysis system. In addition, the company offers RxMAX, a rebate management system designed to assist health plans in managing their relationships with pharmaceutical manufacturers; and Zynchros, which provides a suite of formulary management tools to help payers manage their formulary programs and to maintain Medicare Part D compliance in their programs.
It serves various organizations in the pharmaceutical supply chain, such as pharmacy benefit managers, managed care organizations, retail pharmacy chains, self-insured employer groups, unions, third party health care plan administrators, and state and federal government entities.
Shares have formed a "double bottom" formation and prices are expected to move higher out of this formation. Note that the company has declared a 2-for-1 stock split effective October 1, 2012.
52-Week Trading Range: $40.36 - $104.79
Last Trade: $93.00
Stop Loss: $88.31
Target Price: $102.65
CTRX reached our target price. We closed the position and moved the proceed into another trade.
